sunday 23 sEpTEMbEr - ehmtic 2012

Recommendations

Info

60 EHMTIC20I2 European Headache and Migraine Trust International Congress • TEACHING COURSES • SCIENTIFIC SESSIONS • DEBATES • SATELLITE SYMPOSIA • POSTER PRESENTATIONS • EXHIBITS www.ihc2013.com IHC 2013 IHC 2013 June 27-30 John B. Hynes Veterans Memorial Convention Center Hosted by the International Headache Society and the American Headache Society ® IHC 2013 Scientific Committee Michel D. Ferrari, MD, PhD, Leiden, The Netherlands, Co-Chair R. Allan Purdy, MD, FAHS, Halifax, Nova Scotia, Co-Chair Rami Burstein, PhD, Boston, MA Andrew Charles, MD, Los Angeles, CA David W. Dodick, MD, FAHS, Phoenix, AZ Peter J. Goadsby, MD, PhD, FAHS, San Francisco, CA Rigmor H. Jensen, MD, Glostrup, Denmark Massimo Leone, MD, Milan, Italy Arne May, MD, Cologne, Germany Michael Moskowitz, MD, FAHS, Boston, MA Ana Recober, MD, Iowa City, Iowa Jean Schoenen, MD, PhD, Liege, Belgium Stephen D. Silberstein, MD, FAHS, Philadelphia, PA Till Sprenger, MD, Basel, Switzerland Key Dates September 10, 2012 Registration Site Opens October 1, 2012 Abstract Submission Site Opens February 1, 2013 Deadline for Abstract Submission June 27-30, 2013 16th Congress of the International Headache Society Scientific and Administrative Secretariat Talley Management Group, Inc. 19 Mantua Road, Mt. Royal, NJ 08061 Telephone: +856-423-0043 Fax: +856-423-0082 Email: info@ihc2013.com Website: www.ihc2013.com For more information regarding the 16th Congress of the International Headache Society, please visit the congress website at www.ihc2013.com AMERICAN HEADACHE SOCIETY® • 19 Mantua Road, Mt Royal, NJ 08061 • IHC2013@talley.com
EHMTIC20I2 European Headache and Migraine Trust International Congress Poster Programme contInued late BreakIng aBstracts lB01 Nitric oxide synthase, Calcitonin Gene-Related Peptide and inflammatory mechanisms are involved in GTN induced neuronal activation. Ramachandran, R.; Bhatt, K.; Jansen-Olesen, I.; Olesen, J. Glostrup Hospital, Denmark lB02 High frequency headache prevalence and management in primary care. A survey among general practitioners of the Liege area, Belgium. Magis, D; Schoenen, J Headache Research Unit - University Department of Neurology, Liege, Belgium lB03 Short term improvement of migraine headaches during ketogenic diet: a prospective observational study in a dietician clinical setting. Di Lorenzo, C. 1 ; Coppola, G. 2 ; Sirianni, G. 3 ; Pierelli, F. 1 1 2 Sapienza University of Rome, Italy; G.B. Bietti Foundation-IRCCS, Dept of Neurophysiology of Vision and Neurophthalmology, Rome, Italy; 3Wellness and Dietary Medicine, Krom Genetics Institute, Rome, Italy lB04 Changes in clinical migraine picture and in headache frequency in adolescence. Three year prospective study Kalashyan, R Arabkir Medical Center, Armenia lB05 First demonstration of the neuroimmune link in humans using IV Endotoxin and Intradermal Capsaicin in the face and arm Rolan, P.E. 1 ; Hutchinson, M.R. 1 ; Buijs, M. 2 ; Tuke, J. 1 ; Kwok, Y.H. 1 ; Gentgall, M. 1 ; Williams, D. 3 ; Nillsen, N. 1 1 2 3 University of Adelaide, Australia; University of Leiden, Netherlands; University of South Australia, Australia lB06 Post market pilot programme with single pulse transcranial magnetic stimulation (sTMS) for acute treatment of migraine: SpringTMS use in migraine Weatherall, M.W. 1 ; Bhola, R. 2 ; Giffin, N. 3 ; Goadsby, P.J. 4 1 2 3 Princess Margaret Migraine Clinic, London, United Kingdom; eNeura Therapeutics, California, United States; Royal United Hospital, Bath, United Kingdom; 4UCSF, San Francisco, United States lB07 Role of Psychiatric disorders in association of headache and temporomandibular disorders Nazeri, M; Abareghi, F Medical Students Research Committee, Medical Sciences University, Kerman, Iran lB08 PET imaging in healthy subjects and migraineurs suggests CGRP receptor antagonists do not have to act centrally to achieve clinical efficacy Vermeersch, S.G.G. 1 ; de Hoon, J. 1 ; De Saint-Hubert, B. 1 ; Derdelinckx, I. 1 ; Serdons, K. 2 ; Bormans, G. 3 ; Reynders, T. 4 ; Declercq, R. 4 ; De Lepeleire, I. 4 ; Kennedy, W. 5 ; Blanchard, R. 5 ; Marcantonio, E. 5 ; Hargreaves, R. 6 ; Li, C.C. 6 ; Sanabria, S. 6 ; Hostetler, E. 6 ; Joshi, A. 6 ; Evelhoch, J. 6 ; Van Laere, K. 2 1 2 Center for Clinical Pharmacology, Campus Gasthuisberg, University Hospitals Leuven (KU Leuven), Leuv, Belgium; Nuclear Medicine Department, UZ and KU Leuven, Belgium; 3Laboratory for Radiopharmacy, KU Leuven, Belgium; 4Merck Sharp & Dohme (Europe) Inc., Brussels, Belgium; 5Merck Research Laboratories, Upper Gwynedd PA, United States; 6Merck Research Laboratories, West Point PA, United States lB09 Facial spasm and headaches: Should we call it “IIH-Spasm syndrome?” Muzerengi, S; Moor, C; Davies, M University Hospital of North Staffordshire NHS trust, United Kingdom 61
Page 1 and 2:
EHMTIC20I2 European Headache and Mi
Page 3:
EHMTIC20I2 European Headache and Mi
Page 6 and 7:
6 EHMTIC20I2 European Headache and
Page 8 and 9:
8 EHMTIC20I2 European Headache and
Page 10 and 11: 10 EHMTIC20I2 European Headache and
Page 72: EHMTIC20I2 European Headache and Mi
show all

sunday 23 sEpTEMbEr - ehmtic 2012

Create successful ePaper yourself

Delete template?

Save as template?